Lilly’s obesity pill tops 7,000 prescriptions in fourth week, signals modest uptake

Investing.com Gold reports: Lilly’s obesity pill tops 7,000 prescriptions in fourth week, signals modest uptake. Full body text was unavailable at ingest time, so this brief is based on headline context.